EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
1 hedge funds and large institutions have $3.33M invested in EnteroMedics Inc. in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.
1,057% more capital invested
Capital invested by funds: $288K → $3.33M (+$3.04M)
93% less funds holding
Funds holding: 14 → 1 (-13)
93% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHI
SV Health Investors
Boston,
Massachusetts
|
+$4.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$119K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$47K |
| 3 |
D.E. Shaw & Co
New York
|
-$33K |
| 4 |
BlackRock
New York
|
-$31K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SHI
1
SV Health Investors
Boston,
Massachusetts
| $3.33M | +$4.52M | +2,250,958 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| – | -$119K | -67,540 | Closed |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| – | -$47K | -26,825 | Closed |
|
|
4
D.E. Shaw & Co
New York
| – | -$33K | -18,535 | Closed |
|
|
5
BlackRock
New York
| – | -$31K | -17,668 | Closed |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$29K | -16,421 | Closed |
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$17K | -9,600 | Closed |
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$4K | -2,709 | Closed |
|
9
UBS Group
Zurich,
Switzerland
| – | -$3K | -1,940 | Closed |
|
10
Morgan Stanley
New York
| – | -$3K | -1,564 | Closed |
|
|
FANJ
11
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$2K | -949 | Closed |
|
ETRM Hedge Fund Activity: Q4 2017 in Review
1 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q4 2017, worth a combined $3.33M — up 1,057% from $288K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ETRM and 1 opened new positions — a net loss of 13 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was SV Health Investors, opening a new position worth an estimated $4.52M. The largest seller was Vanguard Group, exiting entirely with an estimated $119K sold.
- 1 institutional investor held EnteroMedics Inc. (ETRM) as of Q4 2017, down from 14 in Q3 2017.
- Funds reported $3.33M of EnteroMedics Inc. stock for Q4 2017, up 1,057% quarter-over-quarter.
- 1 fund opened new EnteroMedics Inc. positions in Q4 2017 and 14 closed out, a net change of -13 holders.
- The largest EnteroMedics Inc. buyer in Q4 2017 was SV Health Investors, an estimated $4.52M added.
- The largest EnteroMedics Inc. seller in Q4 2017 was Vanguard Group, an estimated $119K sold.
Based on aggregated 13F filings for Q4 2017.